mhurhangee/ep-ind-claims huggingface dataset:
A process for preparing an aqueous binder composition, the process comprising at least the following steps A) and B): A) preparing carboxylic acid-functional vinyl polymer (Polymer A) by emulsion polymerisation of a monomer composition A comprising the following monomers: Ai) at least one carboxylic acid functional olefinically unsaturated monomer; and Aii) at least one olefinically unsaturated monomer different than Ai); B) preparing vinyl polymer (Polymer B) by emulsion polymerization of a monomer composition B in the presence of Polymer A where the monomer composition B comprises the following monomer(s): Bi) at least one olefinically unsaturated monomer; Bii) optionally carboxylic acid functional olefinically unsaturated monomer different than Bi); where at least part of the carboxylic acid groups of Polymer A are deprotonated to obtain ionic or potentially ionic water-dispersing groups; where the acid value of Polymer B is lower than the acid value of Polymer A; where the weight average molecular weight (Mw) of Polymer B is higher than the weight average molecular weight (Mw) of Polymer A; where the glass transition temperature of Polymer B is equal to or lower than that of Polymer A; where the weight ratio of Polymer A to Polymer B is in the range of from 5:95 to 95:5; and whereby step A) comprises at least a first polymerisation stage of a monomer composition A1 effected in the presence of a chain transfer agent C1 having a water solubility of at least 5 g/L and a subsequent second polymerisation stage of a monomer composition A2 effected in the presence of a chain transfer agent C2 having a water solubility of at most 0.5 g/L, and whereby the second polymerisation stage of step A) is effected in the optional further presence of chain transfer agent C1 having a water solubility of at least 5 g/L whereby the concentration of chain transfer agent C1 having a water solubility of at least 5 g/L in the second polymerisation stage of step A) is at most 35 mole-%, relative to the total molar concentration of chain transfer agent C1 and chain transfer agent C2 present in the second polymerisation stage of step A). A) preparing carboxylic acid-functional vinyl polymer (Polymer A) by emulsion polymerisation of a monomer composition A comprising the following monomers: Ai) at least one carboxylic acid functional olefinically unsaturated monomer; and Aii) at least one olefinically unsaturated monomer different than Ai); Ai) at least one carboxylic acid functional olefinically unsaturated monomer; and Aii) at least one olefinically unsaturated monomer different than Ai); B) preparing vinyl polymer (Polymer B) by emulsion polymerization of a monomer composition B in the presence of Polymer A where the monomer composition B comprises the following monomer(s): Bi) at least one olefinically unsaturated monomer; Bii) optionally carboxylic acid functional olefinically unsaturated monomer different than Bi); Bi) at least one olefinically unsaturated monomer; Bii) optionally carboxylic acid functional olefinically unsaturated monomer different than Bi);
A process for preparing multivesicular liposomal formulations, the process comprising: providing a first emulsion by mixing a first aqueous phase and a volatile water-immiscible solvent phase, said solvent phase comprising at least one amphipathic lipid and at least one neutral lipid; mixing and emulsifying said first emulsion and a second aqueous phase to provide a second emulsion, said second emulsion comprising a continuous aqueous phase; removing the volatile water-immiscible solvent from the second emulsion to form a composition of blank multivesicular liposomal particles; and remote loading one or more acidic non-steroidal anti-inflammatory drugs into said multivesicular liposomes, wherein a gradient of low pH outside the multivesicular liposomes to high pH inside the multivesicular liposomes is present to drive the one or more acidic non-steroidal anti-inflammatory drugs into the multivesicular liposomes; wherein the acidic non-steroidal anti-inflammatory drug is selected from the group consisting of diclofenac, piroxicam, meloxicam and ketorolac. providing a first emulsion by mixing a first aqueous phase and a volatile water-immiscible solvent phase, said solvent phase comprising at least one amphipathic lipid and at least one neutral lipid; mixing and emulsifying said first emulsion and a second aqueous phase to provide a second emulsion, said second emulsion comprising a continuous aqueous phase; removing the volatile water-immiscible solvent from the second emulsion to form a composition of blank multivesicular liposomal particles; and remote loading one or more acidic non-steroidal anti-inflammatory drugs into said multivesicular liposomes, wherein a gradient of low pH outside the multivesicular liposomes to high pH inside the multivesicular liposomes is present to drive the one or more acidic non-steroidal anti-inflammatory drugs into the multivesicular liposomes; wherein the acidic non-steroidal anti-inflammatory drug is selected from the group consisting of diclofenac, piroxicam, meloxicam and ketorolac.
Crankcase ventilation valve, comprising a valve element to be placed on a ventilation aperture in the crankcase, in a crankcase ventilation valve housing or in a housing of a crankcase ventilation filter, a conical spring whose front face with larger diameter is acting upon the valve element, pressing it in a closing position on the ventilation aperture, and a cover to be fixed to the crankcase, the crankcase ventilation valve housing or the housing of the crankcase ventilation filter and supporting the opposite end of the conical spring, characterized in that the valve element is designed as a membrane element which carries a support washer, wherein the support washer is made of metal and supports the conical spring.
A water treatment system configured for use with a pool, the water treatment system comprising: a fluid passageway in fluid communication with the pool; an ozone generator configured to deliver ozone gas to the fluid passageway; and a drain valve assembly positioned downstream of the ozone generator and upstream of the pool, the drain valve assembly comprising: a valve body including an inlet, an outlet, and a drain outlet; and a floating valve disposed within the valve body, wherein the floating valve closes the drain outlet when water enters the inlet of the valve body from the ozone generator and floats upward to open the drain outlet when water enters the outlet of the valve body from the pool. a fluid passageway in fluid communication with the pool; an ozone generator configured to deliver ozone gas to the fluid passageway; and a drain valve assembly positioned downstream of the ozone generator and upstream of the pool, the drain valve assembly comprising: a valve body including an inlet, an outlet, and a drain outlet; and a floating valve disposed within the valve body, wherein the floating valve closes the drain outlet when water enters the inlet of the valve body from the ozone generator and floats upward to open the drain outlet when water enters the outlet of the valve body from the pool. a valve body including an inlet, an outlet, and a drain outlet; and a floating valve disposed within the valve body, wherein the floating valve closes the drain outlet when water enters the inlet of the valve body from the ozone generator and floats upward to open the drain outlet when water enters the outlet of the valve body from the pool.
Polycrystalline porous Al 2 O 3 bodies of molten aluminum oxide comprising an amount of a aluminum oxide of at least 97% by weight and an amount of other oxide alloying components of a total of up to 3% by weight, wherein the Al 2 O 3 bodies comprise a plurality of Al 2 O 3 primary crystals having a crystallite size of between 20 and 100 μm and the Al 2 O 3 bodies exhibit a macroporosity comprising a pore volume of between 5 and 30% by volume, an average diameter of the pores of between 20 and 60 μm and a maximum pore diameter in the range of approx. 100 μm, characterized in that, at the boundaries of the primary crystals, the polycrystalline Al 2 O 3 bodies comprise concentrations of individual TiO 2 comprising extrinsic phases, the extrinsic phases have a diameter of less than 7 μm and are distributed individually either in a punctiform manner or in lines along the primary crystal boundaries.
A method, comprising: determining, by a processor of a device during a system startup phase that starts privileged software processes that initialize the device and that is prior to transitioning to a device operational phase wherein any software present on the device is able to execute, a respective starting fingerprint of memory of each executing process within at least one process other than a kernel process, each executing process in the at least one process being started after the kernel process and during the system startup phase; determining, by the processor during the device operational phase and while a selected executing process is executing, a present fingerprint of memory of the selected executing process where the selected executed process is within the at least one process; determining, by the processor a difference between the respective starting fingerprint of the selected executing process and the present fingerprint of the selected executing process; and reporting, based on determining the difference, an indication of the difference for the selected executing process. determining, by a processor of a device during a system startup phase that starts privileged software processes that initialize the device and that is prior to transitioning to a device operational phase wherein any software present on the device is able to execute, a respective starting fingerprint of memory of each executing process within at least one process other than a kernel process, each executing process in the at least one process being started after the kernel process and during the system startup phase; determining, by the processor during the device operational phase and while a selected executing process is executing, a present fingerprint of memory of the selected executing process where the selected executed process is within the at least one process; determining, by the processor a difference between the respective starting fingerprint of the selected executing process and the present fingerprint of the selected executing process; and reporting, based on determining the difference, an indication of the difference for the selected executing process.
A positive electrode active material for a lithium ion battery which is represented by the following composition formula: Li(Li x Ni 1-x-y M y)O 2+α (in the formula, M represents Mn and Co, 0 ≤ x ≤ 0.1, 0 < y ≤ 0.7, and α > 0.1), wherein a ratio of peak strength on plane to peak strength on plane, which is (Ps104/Ps003), is 0.9 or less and 2θ of plane is 64.6° or more according to powder X-ray diffraction using CuKα radiation.
A polynucleotide comprising a GBA nucleotide sequence, wherein the GBA nucleotide sequence encodes a β-Glucocerebrosidase (GCase) protein and wherein the GBA nucleotide sequence comprises a sequence that is: (i) 100% identical to SEQ ID NO: 1 or SEQ ID NO: 5; (ii) at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5%, or at least 99.8% identical to SEQ ID NO: 1 or SEQ ID NO: 5, wherein the GCase encoded by the GBA nucleotide sequence has GCase activity and is expressed in human liver cells at higher levels compared to a GCase encoded by a wild type GBA nucleotide sequence in an otherwise identical reference polynucleotide; and/or (iii) a variant of SEQ ID NO: 1 or SEQ ID NO: 5 encoding a GCase protein having GCase activity, wherein the variant is identical to SEQ ID NO: 1 or SEQ ID NO: 5 respectively except that it comprises nucleotide substitutions such that the GCase protein has 1, up to 2, up to 3, up to 4, up to 5, up to 6, up to 7, up to 8, up to 9, or up to 10 amino acid substitutions relative to the wild type GCase amino acid sequence of SEQ ID NO: 25, further wherein the GCase encoded by the GBA nucleotide is expressed in human liver cells at higher levels compared to a GCase encoded by a wild type GBA nucleotide sequence in an otherwise identical reference polynucleotide. (i) 100% identical to SEQ ID NO: 1 or SEQ ID NO: 5; (ii) at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, at least 99.5%, or at least 99.8% identical to SEQ ID NO: 1 or SEQ ID NO: 5, wherein the GCase encoded by the GBA nucleotide sequence has GCase activity and is expressed in human liver cells at higher levels compared to a GCase encoded by a wild type GBA nucleotide sequence in an otherwise identical reference polynucleotide; and/or (iii) a variant of SEQ ID NO: 1 or SEQ ID NO: 5 encoding a GCase protein having GCase activity, wherein the variant is identical to SEQ ID NO: 1 or SEQ ID NO: 5 respectively except that it comprises nucleotide substitutions such that the GCase protein has 1, up to 2, up to 3, up to 4, up to 5, up to 6, up to 7, up to 8, up to 9, or up to 10 amino acid substitutions relative to the wild type GCase amino acid sequence of SEQ ID NO: 25, further wherein the GCase encoded by the GBA nucleotide is expressed in human liver cells at higher levels compared to a GCase encoded by a wild type GBA nucleotide sequence in an otherwise identical reference polynucleotide.
Immediate-release tablets for oral administration consisting of: Mifepristone 6% w/w; Microcristalline Cellulose (with a water content 1-10% w/w) 85.7% w/w; Polyvinylpyrrolidone 4% w/w; Croscarmellose Sodium 3% w/w; Magnesium Stearate 1% w/w; Anhydrous Colloidal Silica 0.3 %. Mifepristone 6% w/w; Microcristalline Cellulose (with a water content 1-10% w/w) 85.7% w/w; Polyvinylpyrrolidone 4% w/w; Croscarmellose Sodium 3% w/w; Magnesium Stearate 1% w/w; Anhydrous Colloidal Silica 0.3 %.
A method for capturing specific cells present in blood, the method comprising: centrifuging sampled blood at a centrifugal force of 1000 to 3000 G; and capturing specific cells therefrom onto a hydrophilic polymer layer, wherein the specific cells are cancer cells. centrifuging sampled blood at a centrifugal force of 1000 to 3000 G; and capturing specific cells therefrom onto a hydrophilic polymer layer, wherein the specific cells are cancer cells.
Store, in particular buffer store, for storing bottles or similar containers, comprising a rotor that can be driven in a rotational manner about a machine axis and comprising multiple storing units on the rotor, said storing units being distributed about the machine axis, each said storing unit forming a storing region that extends with the axial direction thereof in a longitudinal direction of the rotor in order to receive multiple containers, in which the stored containers are oriented in a stored position with their container axis transverse or radial to the machine axis, and with a transporting system for introducing the containers into and for dispensing the containers out of the storing regions, characterised in that the transporting system comprises a plurality of transport elements, of which, in each case, at least one transporting element is allocated to each storing unit, and in that container grippers for the containers are provided at the transport elements, and that the container grippers, in each case form a storage space for a container, which can be transported with the associated transporting element in the axial direction of the respective storage region, preferably step by step, and wherein the machine axis is a vertical axis, and that the transport system is configured in such a way that the containers, on being introduced into the respective storing region, are pivoted out of a normal container position, in which the container axis is a vertical axis, into the storing position and, on the dispensing out of the respective storing region, are conversely pivoted out of the storing position into the normal position.
Apparatus for computing mathematical functions comprising: a single pipeline for performing a polynomial approximation, the single pipeline comprising a plurality of stages; and a plurality of data tables corresponding to the at least one of the RCP, SQRT, EXP, or LOG functions operable to be coupled to the single pipeline according to one or more opcodes; wherein each data table includes fewer than 1000 entries; wherein the polynomial approximation includes a polynomial of second degree; wherein the single pipeline is operable for computing at least one of RCP, SQRT, EXP, or LOG functions according to the one or more opcodes; and wherein the polynomial approximation is of the form F(x) = a + b*(x-x0) + c*(x-x0)*(x-x1), where x is the mantissa of a floating point number, x0 is a value smaller than x and x1 is a value larger than x, wherein x0 and x1 are based on a predetermined most significant bit portion of x and values a, b and c are determined from data look up tables according to the predetermined most significant bit portion of x. a single pipeline for performing a polynomial approximation, the single pipeline comprising a plurality of stages; and a plurality of data tables corresponding to the at least one of the RCP, SQRT, EXP, or LOG functions operable to be coupled to the single pipeline according to one or more opcodes;
A method, performed in an accessory device, for managing a remaining wear time of a base plate of an ostomy appliance, wherein the accessory device comprises an interface configured to communicate with one or more devices of an ostomy system, the interface comprising a display, wherein the ostomy system comprises a monitor device and an ostomy appliance configured to be placed on a skin surface of a user, wherein the ostomy appliance comprises a base plate, the method comprising: - obtaining monitor data from the one or more devices, the monitor data being indicative of a physical condition of the base plate, - determining the remaining wear time of the base plate of the ostomy appliance based on the monitor data; - obtaining a user request to take into account at least a part of context data indicative of a context in which the ostomy appliance is operating, - in response to obtaining the user request: - obtaining the at least a part of context data, - adjusting the remaining wear time of the base plate based on the at least a part of context data; and - communicating, via the interface, the adjusted remaining wear time of the base plate. - obtaining monitor data from the one or more devices, the monitor data being indicative of a physical condition of the base plate, - determining the remaining wear time of the base plate of the ostomy appliance based on the monitor data; - obtaining a user request to take into account at least a part of context data indicative of a context in which the ostomy appliance is operating, - in response to obtaining the user request: - obtaining the at least a part of context data, - adjusting the remaining wear time of the base plate based on the at least a part of context data; and - communicating, via the interface, the adjusted remaining wear time of the base plate. - obtaining the at least a part of context data, - adjusting the remaining wear time of the base plate based on the at least a part of context data; and - communicating, via the interface, the adjusted remaining wear time of the base plate.
A method of reproducing content, the method comprising: receiving, by a sync terminal (200; 1000), a first content from a source terminal (100; 900) via a certain network, wherein the first content is content displayed on a screen of the source terminal (100; 900); reproducing, by the sync terminal (200; 1000), the first content in a mirroring mode during a certain time (operation S301); receiving from the source terminal and buffering, by the sync terminal (200; 1000), video data during the certain time, the video data corresponding to a second content, wherein the second content is content that is to be reproduced in a streaming mode after the certain time (operation S303); and reproducing, by the sync terminal (200; 1000), the second content in a streaming mode after the certain time by using the buffered video data (operation S305); wherein the mirroring mode is an operation mode for transmitting the video data obtained by compressing the screen of the source terminal (100; 900) in real time and reproduced by the sync terminal (200; 1000) in real time; and wherein the streaming mode is another operation mode for receiving and reproducing original content data stored in the source terminal (100; 900) or an external device. receiving, by a sync terminal (200; 1000), a first content from a source terminal (100; 900) via a certain network, wherein the first content is content displayed on a screen of the source terminal (100; 900); reproducing, by the sync terminal (200; 1000), the first content in a mirroring mode during a certain time (operation S301); receiving from the source terminal and buffering, by the sync terminal (200; 1000), video data during the certain time, the video data corresponding to a second content, wherein the second content is content that is to be reproduced in a streaming mode after the certain time (operation S303); and reproducing, by the sync terminal (200; 1000), the second content in a streaming mode after the certain time by using the buffered video data (operation S305); wherein the mirroring mode is an operation mode for transmitting the video data obtained by compressing the screen of the source terminal (100; 900) in real time and reproduced by the sync terminal (200; 1000) in real time; and wherein the streaming mode is another operation mode for receiving and reproducing original content data stored in the source terminal (100; 900) or an external device.
Tool for a dismantlable medical instrument, with: a first component, which surrounds a cavity for receiving a distal end of a shank; a second component with several catches, which are distributed uniformly about the inner circumference of the cavity and at equal angle distances from each other, which protrude radially into the cavity from the surface of the cavity, which surface has the shape of the jacket of a circular cylinder, and are provided to form a bayonet connection and designed to engage from outside in slits (25, 26) or outwardly open grooves at the distal end of the shank which protrudes into the cavity, wherein the first component has recesses into which the second component is fitted, wherein a radially outer end or a radially outer area of each catch completely fills a respective recess of the recesses. a first component, which surrounds a cavity for receiving a distal end of a shank; a second component with several catches, which are distributed uniformly about the inner circumference of the cavity and at equal angle distances from each other, which protrude radially into the cavity from the surface of the cavity, which surface has the shape of the jacket of a circular cylinder, and are provided to form a bayonet connection and designed to engage from outside in slits (25, 26) or outwardly open grooves at the distal end of the shank which protrudes into the cavity, wherein the first component has recesses into which the second component is fitted, wherein a radially outer end or a radially outer area of each catch completely fills a respective recess of the recesses.